 Home > Medical News > Latest Medical News > Trilaciclib introduced by Simcere has been approved for clinical use

Trilaciclib introduced by Simcere has been approved for clinical use

 Last Update: 2021-06-22
 Source: Internet
 Author: User

Tags

astrazeneca press release

sedalia medical center

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The latest announcement by the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China shows that Trilaciclib for injection, jointly declared by Simcere and G1 Therapeutics, has obtained an implied license for a clinical trial to prescribe the treatment of triple-negative breast cancer
.

Simcere Pharmaceuticals issued a press release stating that it will initiate a clinical trial of trilaciclib metastatic triple-negative breast cancer in China

Screenshot source: CDE official website

Public information shows that trilaciclib is a CDK 4/6 inhibitor developed by G1 Therapeutics
.

In August 2020, Simcere Pharmaceutical obtained the development and commercialization rights of all indications of the drug in Greater China (Mainland China, Hong Kong, Macau and Taiwan)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.